Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 22 | 2023 | 815 | 3.740 |
Why?
|
| Interleukin-10 | 11 | 2023 | 478 | 3.390 |
Why?
|
| Hyaluronic Acid | 7 | 2021 | 168 | 2.110 |
Why?
|
| Cicatrix | 4 | 2023 | 208 | 1.840 |
Why?
|
| Fibroblasts | 8 | 2021 | 1682 | 1.570 |
Why?
|
| Neovascularization, Physiologic | 8 | 2022 | 345 | 1.500 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2022 | 13 | 1.400 |
Why?
|
| Lignin | 2 | 2023 | 12 | 1.120 |
Why?
|
| Gene Transfer Techniques | 5 | 2015 | 716 | 0.880 |
Why?
|
| Hymecromone | 1 | 2021 | 6 | 0.840 |
Why?
|
| Wound Infection | 5 | 2022 | 54 | 0.840 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2015 | 224 | 0.830 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 46 | 0.820 |
Why?
|
| Surgical Wound | 1 | 2022 | 48 | 0.810 |
Why?
|
| Skin | 5 | 2023 | 1259 | 0.790 |
Why?
|
| Antioxidants | 1 | 2023 | 507 | 0.710 |
Why?
|
| Fetal Development | 3 | 2015 | 120 | 0.680 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 669 | 0.600 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 1054 | 0.580 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 1121 | 0.560 |
Why?
|
| Hyperoxia | 1 | 2018 | 133 | 0.560 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 161 | 0.550 |
Why?
|
| Dependovirus | 3 | 2013 | 135 | 0.550 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 21 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 14 | 2023 | 6942 | 0.520 |
Why?
|
| Nanofibers | 2 | 2011 | 22 | 0.520 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 106 | 0.510 |
Why?
|
| Pseudomonas Infections | 3 | 2022 | 156 | 0.510 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 630 | 0.490 |
Why?
|
| Mice | 24 | 2023 | 34495 | 0.480 |
Why?
|
| Extracellular Matrix | 6 | 2020 | 554 | 0.470 |
Why?
|
| Animals | 31 | 2023 | 59536 | 0.450 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2018 | 713 | 0.430 |
Why?
|
| NF-kappa B | 2 | 2018 | 1549 | 0.420 |
Why?
|
| Skin Ulcer | 1 | 2011 | 77 | 0.400 |
Why?
|
| Viral Proteins | 1 | 2014 | 435 | 0.390 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 482 | 0.390 |
Why?
|
| Genetic Vectors | 2 | 2013 | 1694 | 0.380 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2022 | 1533 | 0.370 |
Why?
|
| Cells, Cultured | 8 | 2019 | 5637 | 0.370 |
Why?
|
| Gene Expression | 1 | 2018 | 3570 | 0.360 |
Why?
|
| Tissue Engineering | 2 | 2011 | 269 | 0.360 |
Why?
|
| Signal Transduction | 3 | 2020 | 11965 | 0.360 |
Why?
|
| Vagina | 2 | 2023 | 317 | 0.360 |
Why?
|
| Proteolysis | 1 | 2011 | 370 | 0.350 |
Why?
|
| Adenoviridae | 2 | 2015 | 1459 | 0.340 |
Why?
|
| Pulmonary Fibrosis | 2 | 2020 | 170 | 0.320 |
Why?
|
| Lung | 2 | 2018 | 3151 | 0.310 |
Why?
|
| Estrogens | 2 | 2023 | 751 | 0.310 |
Why?
|
| Keratinocytes | 3 | 2016 | 241 | 0.270 |
Why?
|
| Immune Tolerance | 2 | 2019 | 403 | 0.270 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2022 | 233 | 0.230 |
Why?
|
| Amnion | 1 | 2023 | 33 | 0.230 |
Why?
|
| Bandages | 2 | 2020 | 71 | 0.220 |
Why?
|
| Inovirus | 1 | 2022 | 3 | 0.220 |
Why?
|
| Cell Movement | 3 | 2015 | 2466 | 0.210 |
Why?
|
| Molecular Weight | 2 | 2020 | 629 | 0.210 |
Why?
|
| Propylene Glycol | 1 | 2021 | 10 | 0.210 |
Why?
|
| Hydrogels | 2 | 2021 | 123 | 0.210 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 260 | 0.210 |
Why?
|
| Biofilms | 2 | 2022 | 199 | 0.200 |
Why?
|
| Administration, Cutaneous | 1 | 2021 | 141 | 0.200 |
Why?
|
| Dermis | 1 | 2021 | 65 | 0.200 |
Why?
|
| Gelatin | 1 | 2021 | 49 | 0.200 |
Why?
|
| Kidney | 2 | 2020 | 2146 | 0.190 |
Why?
|
| Skin Care | 1 | 2020 | 18 | 0.190 |
Why?
|
| Financing, Organized | 1 | 2020 | 21 | 0.190 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 53 | 0.180 |
Why?
|
| Ethanol | 1 | 2021 | 264 | 0.180 |
Why?
|
| Collagen | 1 | 2023 | 752 | 0.180 |
Why?
|
| Debridement | 1 | 2020 | 123 | 0.180 |
Why?
|
| Water | 1 | 2021 | 361 | 0.180 |
Why?
|
| Inflammation | 4 | 2022 | 2522 | 0.170 |
Why?
|
| Pseudomonas Phages | 1 | 2019 | 10 | 0.170 |
Why?
|
| Writing | 1 | 2020 | 104 | 0.170 |
Why?
|
| Oxygen | 1 | 2023 | 754 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 1077 | 0.160 |
Why?
|
| Gastrostomy | 1 | 2020 | 180 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 1489 | 0.160 |
Why?
|
| Phagocytosis | 1 | 2019 | 260 | 0.160 |
Why?
|
| Bleomycin | 1 | 2019 | 467 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 279 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 446 | 0.150 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 169 | 0.140 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 241 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 1033 | 0.140 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 399 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 450 | 0.140 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 292 | 0.140 |
Why?
|
| Genetic Therapy | 2 | 2015 | 1616 | 0.140 |
Why?
|
| Actins | 1 | 2018 | 608 | 0.130 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 7 | 0.130 |
Why?
|
| Intestines | 1 | 2020 | 686 | 0.130 |
Why?
|
| Receptors, Notch | 1 | 2018 | 383 | 0.130 |
Why?
|
| Transduction, Genetic | 2 | 2013 | 475 | 0.130 |
Why?
|
| Allergens | 1 | 2017 | 247 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 324 | 0.120 |
Why?
|
| Macrophages | 1 | 2020 | 1304 | 0.120 |
Why?
|
| Cytokines | 2 | 2020 | 2809 | 0.120 |
Why?
|
| Capillaries | 2 | 2011 | 99 | 0.120 |
Why?
|
| Palate | 1 | 2013 | 22 | 0.120 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 194 | 0.110 |
Why?
|
| Myocardium | 1 | 2020 | 1313 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 7222 | 0.110 |
Why?
|
| Skin Physiological Phenomena | 1 | 2013 | 43 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 2139 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 299 | 0.110 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.110 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 216 | 0.110 |
Why?
|
| Parvoviridae Infections | 1 | 2012 | 38 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 1618 | 0.110 |
Why?
|
| Viral Tropism | 1 | 2012 | 40 | 0.110 |
Why?
|
| Saliva | 1 | 2013 | 231 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 581 | 0.100 |
Why?
|
| Cell Survival | 1 | 2018 | 3045 | 0.100 |
Why?
|
| Female | 11 | 2023 | 141928 | 0.100 |
Why?
|
| Fetal Therapies | 1 | 2012 | 79 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2020 | 7226 | 0.100 |
Why?
|
| Ointments | 2 | 2021 | 27 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 694 | 0.100 |
Why?
|
| Placenta | 1 | 2015 | 516 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2015 | 5710 | 0.100 |
Why?
|
| Child Development | 1 | 2013 | 255 | 0.090 |
Why?
|
| Trachea | 1 | 2012 | 259 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 1082 | 0.090 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 264 | 0.090 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 891 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2011 | 429 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 3890 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2015 | 3033 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2330 | 0.080 |
Why?
|
| Coculture Techniques | 2 | 2023 | 626 | 0.070 |
Why?
|
| Biomarkers | 2 | 2015 | 5047 | 0.070 |
Why?
|
| Male | 6 | 2021 | 123000 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2011 | 1048 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8223 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2020 | 5542 | 0.060 |
Why?
|
| Collagen Type VII | 1 | 2023 | 2 | 0.060 |
Why?
|
| Chorion | 1 | 2023 | 18 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2021 | 1869 | 0.060 |
Why?
|
| Pseudomonas | 1 | 2022 | 21 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 330 | 0.050 |
Why?
|
| Apoptosis | 1 | 2015 | 7591 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 361 | 0.050 |
Why?
|
| Fetus | 2 | 2015 | 601 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2020 | 157 | 0.050 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2020 | 35 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2019 | 75 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2017 | 1620 | 0.040 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2019 | 23 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 446 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2019 | 94 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 678 | 0.040 |
Why?
|
| Abdomen | 1 | 2020 | 332 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 634 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 664 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 291 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 342 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 615 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 2049 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 1541 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 72 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 1062 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 153 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 793 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 15862 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 249 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2086 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 701 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 7548 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 397 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 734 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2015 | 32848 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2013 | 20 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 957 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 461 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 690 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 943 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 1320 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2314 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 1900 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2011 | 44 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2013 | 242 | 0.030 |
Why?
|
| Materials Testing | 1 | 2011 | 116 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 355 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 360 | 0.020 |
Why?
|
| Pregnancy | 2 | 2015 | 7573 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2020 | 1225 | 0.020 |
Why?
|
| Pneumonia | 1 | 2017 | 751 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 1085 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 135 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 1069 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2011 | 305 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 460 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 4143 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 639 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2992 | 0.020 |
Why?
|
| Heart | 1 | 2015 | 1223 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4320 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 1555 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 77950 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1270 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 848 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 12873 | 0.020 |
Why?
|
| Cell Communication | 1 | 2010 | 509 | 0.020 |
Why?
|
| Middle Aged | 1 | 2014 | 86204 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 37905 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 31252 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 4078 | 0.020 |
Why?
|
| Child | 2 | 2020 | 29154 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 2961 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12221 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 4804 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 70117 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 13310 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 16273 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 12926 | 0.010 |
Why?
|